Position in NBIX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$8,681,663
+$8,161,949 QoQ
Shares Held
51,511
+1205.7% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#167
of 768 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BLAIR WILLIAM & CO/IL holds $57,494,050 across 15 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
583,869 | $41,956,826 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
51,511 | $8,681,663 | |
| 3 | HROW |
Harrow, Inc.
|
39,880 | $1,693,703 | |
| 4 | ETON |
Eton Pharmaceuticals, Inc.
|
32,419 | $1,173,567 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
26,635 | $902,393 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
1,565 | $847,963 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
20,247 | $701,963 | |
| 8 | HLN |
Haleon plc
|
48,903 | $456,264 |
All Filings in NBIX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,681,663 | 51,511 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $519,714 | 3,945 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $638,235 | 4,500 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $626,235 | 4,461 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $586,218 | 4,664 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $687,268 | 6,214 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $881,244 | 6,456 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $742,477 | 6,444 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,077,543 | 7,827 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,185,974 | 8,599 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,069,627 | 8,118 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $976,500 | 8,680 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,345,189 | 14,265 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $31,555,335 | 311,750 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,896,607 | 74,486 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,200,385 | 11,302 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,085,147 | 11,132 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $987,187 | 10,530 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,306,252 | 15,337 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,925,585 | 20,077 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,938,127 | 19,915 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,912,615 | 19,667 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,897,449 | 30,229 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||